CAS: 86347-15-1; 4-(1-(2,3-Dimethylphenyl)Ethyl)-1H-Imidazole Hydrochloride

该化合物是一个化学化合物,其特征为一蛋二氮核心,是一个五人芳香环,内含两个氮原子;该化合物具有一个2,3-二甲基苯基的侧链条,有助于其独特的特性和潜在的生物活动;作为盐化盐,它通常比其自由基质形式更易溶于水中,加强其在各种应用中的用途,特别是在制药方面的用途;它因其在生物系统中的作用而闻名不讳,经常作为其丁丁基和其他重要生物分子的建筑块发挥作用;该化合物可能由于存在氨基环,而出现各种药理活动,包括抗微生物和抗菌性;它的具体相互作用和功效将取决于其结构特征和研究的生物环境.应当观察安全及处理预防措施,正如所有化学物质一样,特别是在实验室环境中.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1021949-47-2 5-[1-(2,3-二甲基苯基... | CAS号86347-14-0 美托咪定 | CAS号576-23-8 3-溴邻二甲苯 | CAS号86347-14-0 美托咪定

合成工艺路线路线简述

  • 合成目标产物 Medetomidine Hydrochloride 主要起始原料 5-[1-(2,3-Dimethylphenyl)Ethenyl]Imidazole
  • 86347-14-0 = 86347-15-1
    反应条件:1.1 Solvents: Acetone; Rt -> -10 °C1.2 Reagents: Hydrochloric Acid Solvents: Water; Ph 2 - 3,Rt
    标题:Commercially Viable Synthesis Of Medetomidine Using A Classical Approach To The Imidazole Ring Formation
    作者:Orekhov,Dmitry
    参考文献:Organic Process Research & Development 日期:2022 卷标:26(11) 页码:3166-3178]

    127-08-2 + 64394-33-8 = 86347-15-1
    反应条件:1.1 Reagents: Bromine Solvents: Methanol; Rt -> -10 °C; -5 °C -> -6 °C; 30 - 35 S,-6 °C -> -9 °C; -5 °C -> -6 °C; 18 H,-6 °C; 10 Min,1 °C; 1 °C -> 0 °C; 2.5 - 3 H,0 °C; 30 Min,0.5 °C1.2 Solvents: Acetonitrile; 21 °C; 19 H,21 °C2.1 Reagents: Cupric Acetate,Ammonia Solvents: 1-Propanol,Water; 3 Min,Rt2.2 Solvents: Water; 2 H,100 °C; 10 - 15 Min,100 °C; 2 H,100 °C; 1 H,16 °C -> 18 °C; 30 Min,18 °C2.3 Reagents: Pentasodium Pentetate Solvents: Ethyl Acetate,Water; 24 H,23 °C2.4 Reagents: Ammonia Solvents: Water; Neutralized,8 °C -> 10 °C2.5 Solvents: Acetone; Rt -> -10 °C2.6 Reagents: Hydrochloric Acid Solvents: Water; Ph 2 - 3,Rt
    标题:Commercially Viable Synthesis Of Medetomidine Using A Classical Approach To The Imidazole Ring Formation
    作者:Orekhov,Dmitry
    参考文献:Organic Process Research & Development 日期:2022 卷标:26(11) 页码:3166-3178]

    35791-94-7 + 134640-85-0 = 86347-15-1
    反应条件:1.1 Reagents: N,N,N′,N′-Tetramethylethylenediamine Catalysts: Tris(Acetylacetonato)Cobalt Solvents: Tetrahydrofuran; 0 °C -> -1 °C; 180 Min,-1 °C; -1 °C -> 20 °C; 1 H,20 °C1.2 Reagents: Hydrochloric Acid Solvents: Water; 20 °C; 40 Min,20 °C1.3 Reagents: 2,2′,3,3′-Tetramethyl-1,1′-Biphenyl Solvents: Methanol; 1 H,-18 °C2.1 Reagents: Bromine Solvents: Methanol; Rt -> -10 °C; -5 °C -> -6 °C; 30 - 35 S,-6 °C -> -9 °C; -5 °C -> -6 °C; 18 H,-6 °C; 10 Min,1 °C; 1 °C -> 0 °C; 2.5 - 3 H,0 °C; 30 Min,0.5 °C2.2 Solvents: Acetonitrile; 21 °C; 19 H,21 °C3.1 Reagents: Cupric Acetate,Ammonia Solvents: 1-Propanol,Water; 3 Min,Rt3.2 Solvents: Water; 2 H,100 °C; 10 - 15 Min,100 °C; 2 H,100 °C; 1 H,16 °C -> 18 °C; 30 Min,18 °C
    标题:Commercially Viable Synthesis Of Medetomidine Using A Classical Approach To The Imidazole Ring Formation
    作者:Orekhov,Dmitry
    参考文献:Organic Process Research & Development 日期:2022 卷标:26(11) 页码:3166-3178]

    91874-85-0 = 86347-15-1
    反应条件:1.1 Reagents: Methyllithium Solvents: Tetrahydrofuran,1,2-Dimethoxyethane1.2 Reagents: Lithium,Ammonia,Ammonium Chloride1.3 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Isopropanol
    标题:Expedient Synthesis Of 4(5)-[1-(2,3-Dimethylphenyl)-1H-Imidazole,The α2-Adrenergic Agonist Medetomidine
    作者:Kudzma,Linas V.; Et Al
    参考文献:Synthesis 日期:1991 卷标:(11) 页码:1021-22]

    2863601-03-8 = 86347-15-1
    反应条件:1.1 Reagents: Cupric Acetate,Ammonia Solvents: 1-Propanol,Water; 3 Min,Rt1.2 Solvents: Water; 2 H,100 °C; 10 - 15 Min,100 °C; 2 H,100 °C; 1 H,16 °C -> 18 °C; 30 Min,18 °C1.3 Reagents: Pentasodium Pentetate Solvents: Ethyl Acetate,Water; 24 H,23 °C1.4 Reagents: Ammonia Solvents: Water; Neutralized,8 °C -> 10 °C1.5 Solvents: Acetone; Rt -> -10 °C1.6 Reagents: Hydrochloric Acid Solvents: Water; Ph 2 - 3,Rt
    标题:Commercially Viable Synthesis Of Medetomidine Using A Classical Approach To The Imidazole Ring Formation
    作者:Orekhov,Dmitry
    参考文献:Organic Process Research & Development 日期:2022 卷标:26(11) 页码:3166-3178]

    2863601-02-7 + 127-08-2 = 86347-15-1
    反应条件:1.1 Solvents: Acetonitrile; 21 °C; 19 H,21 °C2.1 Reagents: Cupric Acetate,Ammonia Solvents: 1-Propanol,Water; 3 Min,Rt2.2 Solvents: Water; 2 H,100 °C; 10 - 15 Min,100 °C; 2 H,100 °C; 1 H,16 °C -> 18 °C; 30 Min,18 °C
    标题:Commercially Viable Synthesis Of Medetomidine Using A Classical Approach To The Imidazole Ring Formation
    作者:Orekhov,Dmitry
    参考文献:Organic Process Research & Development 日期:2022 卷标:26(11) 页码:3166-3178]

    138867-04-6 = 86347-15-1
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Water2.1 Reagents: Methyllithium Solvents: Tetrahydrofuran,1,2-Dimethoxyethane2.2 Reagents: Lithium,Ammonia,Ammonium Chloride2.3 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Isopropanol
    标题:Expedient Synthesis Of 4(5)-[1-(2,3-Dimethylphenyl)-1H-Imidazole,The α2-Adrenergic Agonist Medetomidine
    作者:Kudzma,Linas V.; Et Al
    参考文献:Synthesis 日期:1991 卷标:(11) 页码:1021-22
5-[1-(2,3-二甲基苯基)乙烯基]-1H-咪唑置于5%-Palladium/activated Carbon 氢气,盐酸体系中,用 甲醇,水 作为反应溶剂,-10.0~46.0 °C,210.0 Kpa 条件下,反应 4.5H,以89%的收率获得产物盐酸美托咪啶
参考文献:Method For Preparing Medetomidine And Its Salts
标题:Method For Preparing Medetomidine And Its Salts
摘要:这项发明提供了一种改进的,高效的制备美托咪定及其盐的方法,特别是其药用可接受盐.该方法利用卤代咪唑对格氏试剂的转金属化高反应性,以及随后与2,3-二甲基苯甲醛反应的特点.

海关参考信息

专利信息


专利号:US-10053420-B2
优先权日:2015-01-30
标 题 :Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine
发明人:EKLUND LARS; EEK MARGUS; EKAMBARAM RAMESH; MAASALU ANTS
权利人:CAMBREX KARLSKOGA AB
摘要:There is provided a process for the preparation of a compound of formula (I) as defined herein, wherein said process comprises reacting a compound of formula (II) as defined s herein with one or more suitable Vilsmeier reagent.

专利号:US-6806291-B1
优先权日:2003-10-09
标 题:Analgesic compounds, their synthesis and pharmaceutical compositions containing them
发明人:SUNKEL CARLOS; ALVAREZ-BUILLA JULIO; BAZAN NICOLAS G; VACCARINO ANTHONY
权利人:FOUNDATION FOR THE LSU HEALTH
摘要:New analgesic compounds, which are prepared by the hydrolysis of N-acylated 4-hydroxyphenylamine derivatives, their synthesis and pharmaceutical compositions containing them are disclosed. These compounds surprisingly possess high analgesic activity with little hepatotoxic effect, making them more useful than conventional non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of chronic pain.

专利号:CN-107428648-B
优先权日:2015-01-30
标 题:Process for the preparation of compounds such as 3-arylbutanal useful in the synthesis of medetomidine

专利号:CN-107428648-A
优先权日:2015-01-30
标题 :Process for the preparation of compounds such as 3-arylbutyraldehyde useful in the synthesis of medetomidine

专利号:US-2018009744-A1
优先权日:2015-01-30
标题:Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine

专利号:CN-113800999-A
优先权日:2021-10-18
标题 :A kind of dexmedetomidine hydrochloride impurity and its synthesis method and application
澄源化学有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chembrook.com
电话: 0086 (21) 5276-2796👤
📞澄源化学有限公司 ⚠️参考联系方式

销售电话:0086 (21) 5276-2796
邮箱:info@chembrook.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
济南诚汇双达生物有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jnchsd.com
电话: 0531-58897003 15550412551👤
📞济南诚汇双达生物有限公司 ⚠️参考联系方式

销售电话:0531-58897003 15550412551
邮箱:market@jnchsd.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
西安泰诚化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.taichem.cn
电话: 0086(29)8543-9295👤
📞西安泰诚化工有限公司 ⚠️参考联系方式

销售电话:0086(29)8543-9295
邮箱:sales@taichem.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

西安市雁塔区长安南路375号恒大国际公寓第1幢1单元12层11213号房
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg. 2005 May;32(3):117-27. Review. Review.
3: Cullen LK. Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose. Br Vet J. 1996 Sep;152(5):519-35. Review. Review. Review. German. Review. Review. Review. Review. Review.

合成参考文献


参考文献:10.1007/s11259-011-9492-8
摘要:Schwarz C, Leicht U, Drosse I, Ulrich V, Luibl V, Schieker M, Röcken M. Characterization of adipose-derived equine and canine mesenchymal stem cells after incubation in agarose-hydrogel. Veterinary Research Communications. 2011 Jul 15;35(8):487–99. doi: 10.1007/s11259-011-9492-8.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知